Literature DB >> 3115898

Impairment of macrophage function by inhibitors of ornithine decarboxylase activity.

F Kierszenbaum1, J J Wirth, P P McCann, A Sjoerdsma.   

Abstract

The effects of irreversible inhibition of ornithine decarboxylase on the capacity of murine macrophages to take up a protozoan organism (Trypanosoma cruzi) or inert particles were investigated. Incubation of macrophage cultures with four different ornithine decarboxylase inhibitors, namely, DL-alpha-difluoromethylornithine (DFMO, 0.5 to 20 mM), delta-methyl-acetylenic putrescine (1 to 5 mM), monofluoromethyldehydroornithine ethyl ester (1 to 5 mM), and monofluoromethyldehydroornithine methyl ester (1 to 5 mM), before the addition of the parasites significantly reduced the percentage of macrophages with parasites, indicating that some of the host cells were no longer capable of binding or ingesting the parasite. The average number of trypanosomes per 100 macrophages was also diminished, denoting a lesser phagocytic capacity as a consequence of the treatments. These effects were reversible within 2 h after removal of excess DFMO. No alteration in parasite-macrophage interaction was seen when the trypanosomes were treated with DFMO. That the effects of DFMO on the macrophages probably resulted from a reduction in polyamine levels caused by inhibition of ornithine decarboxylase was indicated by the fact that these effects were not seen when the macrophages were incubated with DFMO in the presence of putrescine, the product of ornithine decarboxylation by ornithine decarboxylase. DFMO treatment of macrophages also inhibited the capacity of these cells to ingest killed parasites or latex beads and thus appeared to generally affect phagocytosis. An effect of DFMO on the susceptibility of macrophages to penetration by the parasites seemed less likely because no significant alteration in cell-parasite association occurred when myoblasts--which, not being phagocytic, can be infected only by membrane penetration--were treated with DFMO. Taken together, these results emphasize a role of ornithine decarboxylase activity and polyamine biosynthesis in macrophage function.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3115898      PMCID: PMC260730          DOI: 10.1128/iai.55.10.2461-2464.1987

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  11 in total

Review 1.  Recent advances in the biochemistry of polyamines in eukaryotes.

Authors:  A E Pegg
Journal:  Biochem J       Date:  1986-03-01       Impact factor: 3.857

2.  Necessity of antibody response in the treatment of African trypanosomiasis with alpha-difluoromethylornithine.

Authors:  A J Bitonti; P P McCann; A Sjoerdsma
Journal:  Biochem Pharmacol       Date:  1986-01-15       Impact factor: 5.858

3.  Isolation of Trypanosoma cruzi from the blood of infected mice by column chromatography.

Authors:  T I Mercado; K Katusha
Journal:  Prep Biochem       Date:  1979

4.  Isolation of Trypanosoma cruzi from blood.

Authors:  D B Budzko; F Kierszenbaum
Journal:  J Parasitol       Date:  1974-12       Impact factor: 1.276

5.  Inhibitory action of elevated levels of adenosine-3':5' cyclic monophosphate on phagocytosis: effects on macrophage-Trypanosoma cruzi interaction.

Authors:  J J Wirth; F Kierszenbaum
Journal:  J Immunol       Date:  1982-12       Impact factor: 5.422

6.  Fibronectin enhances macrophage association with invasive forms of Trypanosoma cruzi.

Authors:  J J Wirth; F Kierszenbaum
Journal:  J Immunol       Date:  1984-07       Impact factor: 5.422

Review 7.  Polyamine metabolism and function.

Authors:  A E Pegg; P P McCann
Journal:  Am J Physiol       Date:  1982-11

8.  Arginine decarboxylase inhibitors reduce the capacity of Trypanosoma cruzi to infect and multiply in mammalian host cells.

Authors:  F Kierszenbaum; J J Wirth; P P McCann; A Sjoerdsma
Journal:  Proc Natl Acad Sci U S A       Date:  1987-06       Impact factor: 11.205

9.  Catalytic irreversible inhibition of Trypanosoma brucei brucei ornithine decarboxylase by substrate and product analogs and their effects on murine trypanosomiasis.

Authors:  A J Bitonti; C J Bacchi; P P McCann; A Sjoerdsma
Journal:  Biochem Pharmacol       Date:  1985-05-15       Impact factor: 5.858

10.  Polyamine metabolism: a potential therapeutic target in trypanosomes.

Authors:  C J Bacchi; H C Nathan; S H Hutner; P P McCann; A Sjoerdsma
Journal:  Science       Date:  1980-10-17       Impact factor: 47.728

View more
  13 in total

1.  Inhibition and killing of fungi by the polyamine oxidase-polyamine system. Antifungal activity of the PAO-polyamine system.

Authors:  S M Levitz; D J DiBenedetto; R D Diamond
Journal:  Antonie Van Leeuwenhoek       Date:  1990-08       Impact factor: 2.271

2.  Host pathogen protein interactions predicted by comparative modeling.

Authors:  Fred P Davis; David T Barkan; Narayanan Eswar; James H McKerrow; Andrej Sali
Journal:  Protein Sci       Date:  2007-10-26       Impact factor: 6.725

3.  Macrophage Metabolism of Apoptotic Cell-Derived Arginine Promotes Continual Efferocytosis and Resolution of Injury.

Authors:  Arif Yurdagul; Manikandan Subramanian; Xiaobo Wang; Scott B Crown; Olga R Ilkayeva; Lancia Darville; Gopi K Kolluru; Christina C Rymond; Brennan D Gerlach; Ze Zheng; George Kuriakose; Christopher G Kevil; John M Koomen; John L Cleveland; Deborah M Muoio; Ira Tabas
Journal:  Cell Metab       Date:  2020-01-30       Impact factor: 27.287

Review 4.  Influence of polyamines on membrane functions.

Authors:  F Schuber
Journal:  Biochem J       Date:  1989-05-15       Impact factor: 3.857

Review 5.  A review on host-pathogen interactions: classification and prediction.

Authors:  R Sen; L Nayak; R K De
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-07-29       Impact factor: 3.267

6.  A high-affinity putrescine-cadaverine transporter from Trypanosoma cruzi.

Authors:  Marie-Pierre Hasne; Isabelle Coppens; Radika Soysa; Buddy Ullman
Journal:  Mol Microbiol       Date:  2010-02-10       Impact factor: 3.501

Review 7.  Eflornithine. A new drug in the treatment of sleeping sickness.

Authors:  I Van Bogaert; A Haemers
Journal:  Pharm Weekbl Sci       Date:  1989-06-23

8.  Inhibition of cyclooxygenase-1 and cyclooxygenase-2 impairs Trypanosoma cruzi entry into cardiac cells and promotes differential modulation of the inflammatory response.

Authors:  Aparecida D Malvezi; Carolina Panis; Rosiane V da Silva; Rafael Carvalho de Freitas; Maria I Lovo-Martins; Vera L H Tatakihara; Nágela G Zanluqui; Edecio Cunha Neto; Samuel Goldenberg; Juliano Bordignon; Sueli F Yamada-Ogatta; Marli C Martins-Pinge; Rubens Cecchini; Phileno Pinge-Filho
Journal:  Antimicrob Agents Chemother       Date:  2014-08-04       Impact factor: 5.191

9.  Effect of difluoromethylornithine (DFMO) on NSAID-induced intestinal injury in rats.

Authors:  R A Erickson; N Rivera
Journal:  Dig Dis Sci       Date:  1992-12       Impact factor: 3.199

10.  Inhibition of host cell invasion and intracellular replication of Trypanosoma cruzi by N,N'-bis(benzyl)-substituted polyamine analogs.

Authors:  S Majumder; F Kierszenbaum
Journal:  Antimicrob Agents Chemother       Date:  1993-10       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.